Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Bayer Lotrimin® and Tinactin® spray products - recalled due to presence of Benzene, USA

2 years ago source www.fda.gov

Recall notice

United States

Bayer is voluntarily recalling all unexpired Lotrimin® AF and Tinactin® spray products with lot numbers beginning with TN, CV, or NAA, distributed between September 2018 to September 2021, to the consumer level due to the presence of benzene in some samples of the products. To date, Bayer has no known reports of adverse events related to this recall.

Benzene is not an ingredient in any of Bayer Consumer Health products. It is important to note that Bayer’s decision to voluntarily recall these products is a precautionary measure and that the levels detected are not expected to cause adverse health consequences in consumers.

Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin. Depending on duration and level of exposure, it can result in cancers including leukemia, and blood cancer of the bone marrow, and blood disorders that can be life-threatening. Benzene is found in the environment from natural sources and human activity. Humans around the world are exposed to it from multiple sources and pathways, including inhalation, through the skin, and orally.

The affected Lotrimin® and Tinactin® spray products are over-the-counter antifungal products, sold individually or in combo packs.

The impacted products are:
- Lotrimin® Anti-Fungal (AF) Athlete's Foot Powder Spray
- Lotrimin® Anti-Fungal Jock Itch (AFJI) Athlete's Foot Powder Spray
- Lotrimin® Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray
- Lotrimin® AF Athlete's Foot Liquid Spray
- Lotrimin® AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
- Tinactin® Jock Itch (JI) Powder Spray
- Tinactin® Athlete’s Foot Deodorant Powder Spray
- Tinactin® Athlete’s Foot Powder Spray
- Tinactin® Athlete’s Foot Liquid Spray

Product images and information on which lot numbers fall under this recall are available at the link below. There are no issues of concern with Lotrimin®/Tinactin® creams, including Lotrimin® Ultra, or any other Bayer products.

The recalled products are all packaged in aerosol spray cans. The products were distributed in the U.S., Puerto Rico, Canada, and Mexico through a variety of retail channels.

Bayer is also notifying its distributors and retailers by letter and is arranging for returns of all voluntarily recalled products. Consumers who have the products that are being recalled should stop using them.

Check the full recall details on www.fda.gov

Company name: Bayer U.S. LLC
Brand name: Lotrimin® AF and Tinactin®
Product recalled: Over the Counter (OTC) antifungal spray products
Reason of the recall: Presence of benzene
FDA Recall date: October 01, 2021

Source: FDA

#drugs #recall #blood #us

Recent Interesting Reports

T

Poor product; not as advertised, Burke VA

2 days ago reported by user-tcjqd122

Received 2 identical orders from 2 different senders:
*Aaron Wang, 3611 S Ashland Ave, Chicago IL 60609
*Deathers Fottys, 3646 S Wolcott Ave, Chicago IL. 60609

I want to return for a refund, but there aren’t any instructions on the return policy. I received two of the … See More
same product, but only paid for one.
See Less

#unorderedpackage

X
Received a bottle that I never ordered, charged our card, wife ordered a mug from Starbucks, and that is when they charged our card twice. My wife thought she was ordering a cup from a Starbucks email, but instead they charged our card twice for almost 200 dollars

Im in Columbus, OH, USA

#onlineshopping #scam #onlinescam #delivery #tampa #florida #us

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it is voluntarily recalling six (6) lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level due to … See More
powder discoloration in some packets leading to decreased potency. The issue was discovered during an accelerated stability test in addition to customer complaints. Sapropterin Dihydrochloride Powder for Oral Solution 100 mg was distributed nationwide to wholesalers/retailers. Dr. Reddy’s Laboratories Inc. has not received any reports of adverse events related to this recall to date.

Reduced efficacy of the product would result in elevated Phenylalaninemia (Phe) levels in patients. Chronically elevated Phe levels in infants and children are likely to cause permanent neurocognitive deficits, including permanent and irreversible intellectual disability, developmental delay, and seizures. Furthermore, elevated Phe levels during pregnancy, especially in early gestation, are associated with microcephaly and congenital heart disease.

The product is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin-(BH4-) responsive Phenylketonuria (PKU) and is packaged in individual packets, 30 per carton. The affected Sapropterin Dihydrochloride Powder for Oral Solution 100mg lots include the following:

- Product Name: Javygtor™ (Sapropterin) Dihydrochloride) Powder for Oral Solution 100 mg, Lot Number: T2202812; T2204053; T2300975; T2300976; T2304356, Expiration date: 07/2025; 10/2025; 02/2026; 02/2026; 08/2026, NDC Number: 43598-097-30; 43598-097-30; 43598-097-30; 43598-097-30; 43598-097-30

- Product Name: Sapropterin Dihydrochloride Powder for Oral Solution 100 mg, Lot Number: T2200352, Expiration date: 12/2024, NDC Number: 43598-477-30

Dr. Reddy’s Laboratories Inc. is notifying its distributors and customers by recall notification letters and is arranging for returns of all recalled products. Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Consumers who have Sapropterin Dihydrochloride Powder for Oral Solution 100 mg which is being recalled should contact their physician before stopping use of the product. Consumers who have Sapropterin Dihydrochloride Powder for Oral Solution 100 mg which is being recalled should return it to their place of purchase.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Dr. Reddy’s Laboratories Inc
Brand name: Dr. Reddy’s
Product recalled: Sapropterin Dihydrochloride Powder for Oral Solution 100 mg
Reason of the recall: Decreased Potency
FDA Recall date: April 23, 2024

Source: www.fda.gov
See Less

#drugs #recall #us

ADM Animal Nutrition, a division of ADM (NYSE: ADM), is expanding the recall announced on March, 30, 2024, to include the following additional products due to elevated levels of magnesium, sodium, calcium and/or phosphorus: Pen Pals® Chicken Starter-Grower (Product Nos.70009AAA46 and 70009AAA44); Pen Pals Egg Maker Complete … See More
(Product No. 70010AAAE4); MaxLean GF Concentrate (Product No. 12354AAA); ShowTec Sow Ration with Thermal Care (Product No. 12343AAA); ShowTec BB 18 BMD (Product No. 18241AGNE4); ShowTec BB 18 BMD/DBZ (Product No. 18241PLM); ShowTec Hi Fat 18 BMD (Product No. 18007AGNE4); ShowTec Lo Fat 15 BMD (Product No. 15350AGN); MoorMan's ShowTec Hi Fat 16 BMD (Product No. 16700AGN); MoorMan's ShowTec Burst Starter w/DF DEN (Product No. 24320CVW); MoorMan’s ShowTec Sale Burst w/DF CTC/DEN (Product No. 24320AYWE4); Pen Pals® Professional Show Rabbit Feed (Product No. 81657AAA); and Pen Pals Professional Rabbit 18 (Product No. 80033AAA). To see more details of each product please visit the link below.

Elevated levels of sodium can cause increased water consumption, reduced feed efficiency, egg production, and growth rate and can be fatal in chickens. Elevated levels of calcium and/or phosphorus can cause reduced feed intake and feed conversion in swine, and elevated levels of magnesium and sodium can cause loose stools, reduced growth rate, and weakness in rabbits.

In case your animals experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance.

Company name: ADM Animal Nutrition
Brand name: Pen Pals, MaxLean, ShowTec, MoorMan's
Product recalled: Chicken, Swine and Rabbit Feed Products
Reason of the recall: Specific lots may contain elevated levels of magnesium, sodium, calcium and/or phosphorus
FDA Recall date: April 11, 2024

Source: www.fda.gov
See Less

#petfood #recall #us

Last 30 days